VCP
SRDX

Verus Capital Partners’s Surmodics SRDX Stock Holding History

Verus Capital Partners’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$10K Hold
300
– – ﹤0.01% 1004
2019
Q4 		$12K Buy
+300
New +$12.6K ﹤0.01% 1062

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Verus Capital Partners's SRDX Position: Q1 2020 in Review

Verus Capital Partners held its Surmodics (SRDX) position steady in Q1 2020 at 300 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #1004.

Verus Capital Partners first reported a position in SRDX in Q4 2019 and has held it in 2 quarters since. The position peaked at $12K in Q4 2019. 127 funds tracked by Wall St. Rank hold SRDX as of Q1 2020.

  • Verus Capital Partners held 300 shares of Surmodics worth $10K as of Q1 2020.
  • Verus Capital Partners left its Surmodics share count unchanged in Q1 2020.
  • Surmodics made up ﹤0.01% of Verus Capital Partners's portfolio in Q1 2020, its #1004 holding.
  • Verus Capital Partners first reported a position in Surmodics in Q4 2019 and has held it in 2 quarters since.
  • Verus Capital Partners's Surmodics position peaked at $12K in Q4 2019.
  • 127 funds tracked by Wall St. Rank held Surmodics as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.